{"organizations": [], "uuid": "e3ff109659890a940cec7d271d49444d8a4ffdef", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-cellular-biomedicine-announces-pla/brief-cellular-biomedicine-announces-plan-to-configure-part-of-shanghai-facility-idUSFWN1PD1F6", "country": "US", "domain_rank": 408, "title": "BRIEF-Cellular Biomedicine Announces Plan To Configure Part Of Shanghai Facility", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-18T23:25:00.000+02:00", "replies_count": 0, "uuid": "e3ff109659890a940cec7d271d49444d8a4ffdef"}, "author": "", "url": "https://www.reuters.com/article/brief-cellular-biomedicine-announces-pla/brief-cellular-biomedicine-announces-plan-to-configure-part-of-shanghai-facility-idUSFWN1PD1F6", "ord_in_thread": 0, "title": "BRIEF-Cellular Biomedicine Announces Plan To Configure Part Of Shanghai Facility", "locations": [], "entities": {"persons": [], "locations": [{"name": "shanghai", "sentiment": "none"}, {"name": "shanghai", "sentiment": "none"}], "organizations": [{"name": "reuters) - cellular biomedicine group inc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "shanghai facility reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 18, 2018 / 9:25 PM / in 7 minutes BRIEF-Cellular Biomedicine Announces Plan To Configure Part Of Shanghai Facility Reuters Staff 1 Min Read \nJan 18 (Reuters) - Cellular Biomedicine Group Inc: \n* CELLULAR BIOMEDICINE GROUP INC - ANNOUNCED PLAN TO CONFIGURE PART OF ITS FACILITY IN SHANGHAI WITH GE HEALTHCAREâ€˜S FLEXFACTORY PLATFORM \n* CELLULAR BIOMEDICINE-AFTER EXECUTION OF NON-BINDING LOI, SEES FLEXFACTORY TO BE OPERATIONAL IN CBMG-GE JOINT LABORATORY OF CELL THERAPY BY END OF 2018 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-18T23:25:00.000+02:00", "crawled": "2018-01-18T23:40:37.010+02:00", "highlightTitle": ""}